Importantly, if sex relates to a time-limited preservation of memory and/or HV in AD, analyses of sex effects should consider both diagnostic trajectory (i.e., normal cognition to MCI to dementia) and presence of biomarkers such as brain amyloid and tau measured by PET or indexed by the cerebrospinal fluid (CSF). The gene discussed is MAPT; the disease is Alzheimer disease.